394 related articles for article (PubMed ID: 21203389)
21. Intermittent screening and treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy: implementation feasibility in a routine healthcare system setting in western Kenya.
Hill J; Ouma P; Oluoch S; Bruce J; Kariuki S; Desai M; Webster J
Malar J; 2020 Nov; 19(1):433. PubMed ID: 33238999
[TBL] [Abstract][Full Text] [Related]
22. Intermittent preventive treatment with Sulphadoxine-Pyrimethamine (IPTp-SP) is associated with protection against sub-microscopic P. falciparum infection in pregnant women during the low transmission dry season in southwestern Cameroon: A Semi - longitudinal study.
Apinjoh TO; Ntui VN; Chi HF; Moyeh MN; Toussi CT; Mayaba JM; Tangi LN; Kwi PN; Anchang-Kimbi JK; Dionne-Odom J; Tita ATN; Achidi EA; Amambua-Ngwa A; Titanji VPK
PLoS One; 2022; 17(9):e0275370. PubMed ID: 36178962
[TBL] [Abstract][Full Text] [Related]
23. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial.
González R; Mombo-Ngoma G; Ouédraogo S; Kakolwa MA; Abdulla S; Accrombessi M; Aponte JJ; Akerey-Diop D; Basra A; Briand V; Capan M; Cot M; Kabanywanyi AM; Kleine C; Kremsner PG; Macete E; Mackanga JR; Massougbodgi A; Mayor A; Nhacolo A; Pahlavan G; Ramharter M; Rupérez M; Sevene E; Vala A; Zoleko-Manego R; Menéndez C
PLoS Med; 2014 Sep; 11(9):e1001733. PubMed ID: 25247709
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of intermittent presumptive treatment with sulfadoxine-pyrimethamine using rapid diagnostic test screening and treatment with dihydroartemisinin-piperaquine at the first antenatal care visit (IPTp-SP+): study protocol for a randomized controlled trial.
Kabuya JB; Ippolito MM; Sikalima J; Tende C; Champo D; Mwakazanga D; Young AMP; Mulenga M; Chongwe G; Manyando C
Trials; 2021 Nov; 22(1):820. PubMed ID: 34801059
[TBL] [Abstract][Full Text] [Related]
25. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
[TBL] [Abstract][Full Text] [Related]
26. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
Gies S; Coulibaly SO; Ouattara FT; Ky C; Brabin BJ; D'Alessandro U
Malar J; 2008 Sep; 7():180. PubMed ID: 18801158
[TBL] [Abstract][Full Text] [Related]
27. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.
Desai M; Gutman J; L'lanziva A; Otieno K; Juma E; Kariuki S; Ouma P; Were V; Laserson K; Katana A; Williamson J; ter Kuile FO
Lancet; 2015 Dec; 386(10012):2507-19. PubMed ID: 26429700
[TBL] [Abstract][Full Text] [Related]
28. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
[TBL] [Abstract][Full Text] [Related]
29. A new strategy and its effect on adherence to intermittent preventive treatment of malaria in pregnancy in Uganda.
Mbonye AK; Yanow S; Birungi J; Magnussen P
BMC Pregnancy Childbirth; 2013 Sep; 13():178. PubMed ID: 24053142
[TBL] [Abstract][Full Text] [Related]
30. Factors influencing adherence to the new intermittent preventive treatment of malaria in pregnancy policy in Keta District of the Volta region, Ghana.
Vandy AO; Peprah NY; Jerela JY; Titiati P; Manu A; Akamah J; Maya ET; Torpey K
BMC Pregnancy Childbirth; 2019 Nov; 19(1):424. PubMed ID: 31747927
[TBL] [Abstract][Full Text] [Related]
31. Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.
Anchang-Kimbi JK; Kalaji LN; Mbacham HF; Wepnje GB; Apinjoh TO; Ngole Sumbele IU; Dionne-Odom J; Tita ATN; Achidi EA
Malar J; 2020 Mar; 19(1):100. PubMed ID: 32122339
[TBL] [Abstract][Full Text] [Related]
32. Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy.
Sicuri E; Fernandes S; Macete E; González R; Mombo-Ngoma G; Massougbodgi A; Abdulla S; Kuwawenaruwa A; Katana A; Desai M; Cot M; Ramharter M; Kremsner P; Slustker L; Aponte J; Hanson K; Menéndez C
PLoS One; 2015; 10(4):e0125072. PubMed ID: 25915616
[TBL] [Abstract][Full Text] [Related]
33. Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique.
Arnaldo P; Rovira-Vallbona E; Langa JS; Salvador C; Guetens P; Chiheb D; Xavier B; Kestens L; Enosse SM; Rosanas-Urgell A
Malar J; 2018 Mar; 17(1):109. PubMed ID: 29530044
[TBL] [Abstract][Full Text] [Related]
34. Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy.
Chico RM; Chandramohan D
Trop Med Int Health; 2011 Jul; 16(7):774-85. PubMed ID: 21477099
[TBL] [Abstract][Full Text] [Related]
35. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
[TBL] [Abstract][Full Text] [Related]
36. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi.
Verhoeff FH; Brabin BJ; Chimsuku L; Kazembe P; Russell WB; Broadhead RL
Ann Trop Med Parasitol; 1998 Mar; 92(2):141-50. PubMed ID: 9625909
[TBL] [Abstract][Full Text] [Related]
37. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
Azizi SC
BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
[TBL] [Abstract][Full Text] [Related]
38. Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon.
Bouyou-Akotet MK; Mawili-Mboumba DP; Kombila M
BMC Pregnancy Childbirth; 2013 Feb; 13():52. PubMed ID: 23442536
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
Mosha D; Chilongola J; Ndeserua R; Mwingira F; Genton B
Trop Med Int Health; 2014 Sep; 19(9):1048-56. PubMed ID: 24965022
[TBL] [Abstract][Full Text] [Related]
40. Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.
Hommerich L; von Oertzen C; Bedu-Addo G; Holmberg V; Acquah PA; Eggelte TA; Bienzle U; Mockenhaupt FP
Malar J; 2007 Nov; 6():144. PubMed ID: 17996048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
